Englander Institute for Precision Medicine
Dr. George Coukos

Dr. George Coukos, a physician-scientist and international authority on tumor immunology and cellular immunotherapy, is joining Weill Cornell Medicine on Feb. 1 to lead the new Ludwig Laboratory for Cell Therapy. He previously was founding director of the Ludwig Lausanne Branch in Switzerland.

The Ludwig Laboratory for Cell Therapy will be housed within the Sandra and Edward Meyer Cancer Center. It will build on Dr. Coukos’s scientific achievements as director of Lausanne Branch, among...

Director Olivier Elemento, Ph.D.

“Vision, Growth, and Priorities.” 

Highlights from the December 18th Town Hall by EIPM Director Olivier Elemento, Ph.D.  

The Englander Institute for Precision Medicine gathered faculty, staff, and trainees for our annual Town Hall meeting on December 18th led by Director Olivier Elemento, Ph.D., who used the occasion to focus on the EIPM’s future direction, ongoing initiatives, and strategic priorities, highlighting both significant accomplishments...

Credit: Shutterstock

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely to benefit from PARP inhibitor cancer treatments, according to a study led by Weill Cornell Medicine and NewYork-Presbyterian investigators. The findings suggest further development of this approach is merited.